Find information on Biological Kerecis Procedure coding, ICD-10 codes, and CPT codes for Kerecis Omega3 Graft or Fish Skin Graft. Learn about clinical documentation requirements for Kerecis Omega3 wound care and Fish Skin Graft applications in healthcare settings. This resource provides guidance for accurate medical coding and billing for the Biological Kerecis Procedure, supporting proper reimbursement and healthcare compliance.
Also known as
Other specified disorders of the skin and subcutaneous tissue
This code captures other specified skin and subcutaneous tissue disorders, potentially including fish skin grafts.
Urticaria and erythema
If the procedure is for skin conditions like burns resulting in erythema, these codes may be applicable.
Burns and corrosions
Kerecis grafts are often used for burns; these codes classify the burn itself.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the Kerecis procedure for a burn?
When to use each related code
| Description |
|---|
| Biologic graft using fish skin. |
| Skin substitute from human donor. |
| Skin graft from patient's own body. |
Lack of anatomical location documentation for Kerecis application may lead to coding errors and claim denials. ICD-10 requires site specificity.
Omega3 or fish skin descriptors may lead to incorrect product coding. Verify appropriate HCPCS code for Kerecis Omega3 Graft.
Insufficient documentation supporting the medical necessity of the biological Kerecis procedure can cause audit issues and rejected claims. Clearly justify its use.
Q: What are the evidence-based clinical applications of Kerecis Omega3 fish skin grafts in wound management for different tissue types?
A: Kerecis Omega3 grafts, derived from fish skin, have demonstrated efficacy in various wound types across diverse tissue applications. Clinical studies support their use in treating chronic wounds like diabetic foot ulcers, venous leg ulcers, and pressure ulcers. Evidence also suggests positive outcomes in acute surgical wounds, trauma wounds, and burns. The intact collagen and omega-3 fatty acids within the graft are believed to promote tissue regeneration, reduce inflammation, and modulate the wound healing environment. Explore how Kerecis Omega3 grafts can be integrated into your wound care protocols for specific tissue types by reviewing published clinical trials and case studies.
Q: How does the Kerecis biological tissue matrix compare to other biological skin substitutes and traditional wound care modalities for complex wound reconstruction?
A: Compared to traditional wound care modalities like dressings and synthetic grafts, Kerecis biological tissue matrix offers distinct advantages in complex wound reconstruction. Unlike some other biological skin substitutes derived from mammalian sources, the fish-derived nature of Kerecis minimizes the risk of disease transmission. The unique structure of the Kerecis graft promotes cellular infiltration, angiogenesis, and tissue integration, potentially leading to faster and more complete wound closure compared to traditional methods. Moreover, the omega-3 fatty acids present in the graft have anti-inflammatory and immunomodulatory properties that can further enhance healing. Consider implementing Kerecis grafts in your practice for challenging wound cases where traditional approaches have proven insufficient. Learn more about comparative studies evaluating Kerecis against other wound care options.
Patient presented with a [wound type, e.g., chronic diabetic foot ulcer, burn wound, venous stasis ulcer] measuring [wound dimensions, e.g., 3 cm x 2 cm x 0.5 cm] located on the [wound location, e.g., plantar aspect of the right foot, left lateral lower leg]. Wound bed appeared [wound bed description, e.g., fibrinous, with moderate exudate, necrotic tissue present]. Surrounding skin was [periwound skin description, e.g., erythematous, edematous, intact]. Patient reported [patient symptoms, e.g., pain level 5/10, limited mobility, malodor]. Diagnosis of [specific wound diagnosis, e.g., Wagner Grade 2 diabetic foot ulcer] confirmed. Given the clinical presentation and the need for advanced wound care, a biological kerecis procedure using a Kerecis Omega3 graft, also known as a fish skin graft, was deemed medically necessary. This treatment modality was selected to promote wound healing, reduce inflammation, and manage pain. The Kerecis Omega3 graft was applied directly to the wound bed following appropriate debridement. The wound was then dressed with [dressing type, e.g., a non-adherent dressing and sterile gauze]. Patient education was provided regarding wound care instructions, including dressing changes, offloading techniques, and signs of infection. Patient tolerated the procedure well. Follow-up scheduled in [timeframe, e.g., one week] to assess wound healing progress and adjust treatment plan as needed. ICD-10 code [appropriate ICD-10 code] and CPT code [appropriate CPT code, e.g., for application of the biological skin substitute] were used for billing purposes.